- In January 2025, IMQ Group entered the Indian market by launching Elettra Tech Labs, a joint venture focused on testing and inspection services for medical devices and electrical and electronic products. This expansion strengthens IMQ’s global presence, supporting Indian businesses in meeting rigorous quality and safety standards while facilitating international market access. The initiative aligns with India’s growing medical device sector, leveraging advanced testing technologies to enhance compliance and innovation
- In March 2024, Stryker expanded its prototype and testing facility in India, marking a significant milestone in its research and development footprint. The 55,600-square-foot facility integrates cutting-edge infrastructure and enhanced microbiology capabilities, strengthening product assurance and innovation. This expansion supports rigorous life cycle testing of medical devices, ensuring compliance with global regulatory standards. The facility also features advanced prototyping tools, including plastic 3D printing and metal machining, reinforcing Stryker’s commitment to medical technology advancements
- In March 2024, TidalSense, a UK-based respiratory device company, launched a pilot study to evaluate its N-Tidal device, designed to diagnose asthma in children. Conducted in partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust, the study involves 75 children under five years old with asthma and viral wheeze. Unlike traditional spirometry tests, which require complex breathing maneuvers, N-Tidal uses capnography to measure CO₂ levels during normal breathing, making diagnosis easier and more accessible
- In June 2023, TÜV SÜD inaugurated a state-of-the-art microbiology and chemistry laboratory in New Brighton, Minnesota, reinforcing its commitment to high-quality medical device testing services. Accredited under ISO 17025, the facility specializes in biological and chemical testing, supporting medical device companies in accelerating research and development. Equipped with advanced technology, the lab offers microbiology, reusable device testing, chemistry, biocompatibility, and packaging assessments. This expansion strengthens TÜV SÜD’s global laboratory network, ensuring precision and compliance for medical innovation
- In July 2022, Eurofins Scientific acquired WESSLING Hungary, strengthening its environmental, food, and BioPharma product testing capabilities across Europe. WESSLING Hungary, a leading laboratory, generated €15 million in revenue in 2021 and employed over 300 staff, reinforcing Eurofins’ commitment to high-quality analytical services
